Human medicines
Phlogenzyme
The marketing authorization holder informed its supplied customers in a letter dated June 28, 2011, that due to a minor deviation (falling below the…
Calcium "Fresenius"-Ampullen
The marketing authorization holder informed its supplied customers by letter dated 06.06.2011 that a precautionary recall is being carried out due to…
Pridax
The marketing authorization holder informed its supplied customers in a letter dated May 26, 2011, that the degradation product prostaglandin A1…
Braunoderm
The marketing authorization holder informed its supplied customers in a letter dated May 20, 2011, that the content of available iodine in the three…
Prezista
The marketing authorization holder informed its supplied customers in a letter dated May 11, 2011, that due to reports of an unpleasant, moldy odor,…
Navelbine
The marketing authorization holder informed its supplied customers by letter dated May 3, 2011, that an atypically elevated value of a known,…
Cytostatics Decree
Decree concerning "Standards for the preparation for use, application and disposal of cytostatic drugs" (acc. to § 2 Z 12 GQG).
See related files.
Thioguanin "Aspen"
In a letter dated April 29, 2011, the marketing authorization holder informed its customers that the two batches had to be exchanged because routine…
TechneScan LyoMAA
The marketing authorization holder has informed its supplied customers by letter dated April 28, 2011, that a small piece of glass has been detected…
Peritoneal dialysis solutions
Baxter Healthcare has identified elevated levels of endotoxin in some batches of the above peritoneal dialysis solutions at its manufacturing facility…
